5‐HT 2A and α1b‐adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants
Abstract
Addictive properties of drugs of misuse are generally considered to be mediated by an increased release of dopamine (DA) in the ventral striatum. However, recent experiments indicated an implication of alpha1b-adrenergic receptors in behavioural responses to psychostimulants and opiates. We show now that DA release induced in the ventral striatum by morphine (20 mg/kg) is completely blocked by prazosin (1 mg/kg), an alpha1-adrenergic antagonist. However, morphine-induced increases in DA release in the ventral striatum were found to be similar in mice deleted for the alpha1b-adrenergic receptor (alpha1b-AR KO) and in wild-type (WT) mice, suggesting the presence of a compensatory mechanism. This acute morphine-evoked DA release was completely blocked in alpha1b-AR KO mice by SR46349B (1 mg/kg), a 5-HT2A antagonist. SR46349B also completely blocked, in alpha1b-AR KO mice, the locomotor response and the development of behavioural sensitization to morphine (20 mg/kg) and D-amphetamine (2 mg/kg). Accordingly, the concomitant blockade of 5-HT2A and alpha1b-adrenergic receptors in WT mice entirely blocked acute locomotor responses but also the development of behavioural sensitization to morphine, D-amphetamine or cocaine (10 mg/kg). We observed, nevertheless, that inhibitory effects of each antagonist on locomotor responses to morphine or D-amphetamine were more than additive (160%) in naïve WT mice but not in those sensitized to either drug. Because of these latter data and the possible compensation by 5-HT2A receptors for the genetic deletion of alpha1b-adrenergic receptors, we postulate the existence of a functional link between these receptors, which vanishes during the development of behavioural sensitization.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MDMA strongly affects 5-HT2A receptors, which are important mediators of behavioral sensitization.
“MDMA also strongly affects 5-HT2A receptors, which are important mediators of behavioral sensitization (47–49).”
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859 · see citing works
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346 · see citing works
Robinson, T. G., & BECKER, J. (1986) · Brain Research · doi:10.1016/s0006-8993(86)80193-7 · Cited by 2,110 · see citing works
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968 · see citing works
Pazos, Á., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855 · see citing works
Kelly, P. H., Seviour, P. W., & Iversen, S. D. (1975) · Brain Research · doi:10.1016/0006-8993(75)90233-4 · Cited by 1,740 · see citing works
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637 · see citing works
Addiction, Dopamine, and the Molecular Mechanisms of Memory
Berke, J. D., & Hyman, S. E. (2000) · Neuron · doi:10.1016/s0896-6273(00)81056-9 · Cited by 1,167 · see citing works
Pazos, Á., Cortés, R., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90857-1 · Cited by 824 · see citing works
Sesack, S. R., & Pickel, V. M. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903200202 · Cited by 820 · see citing works
Binding of antipsychotic drugs to human brain receptors
Richelson, E., & Souder, T. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00911-5 · Cited by 608 · see citing works
Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536 · see citing works
Ichikawa, J., Ishii, H., Bonaccorso, S., Fowler, W. L., O'Laughlin, I. A., & Meltzer, H. Y. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00154.x · Cited by 495 · see citing works
Noradrenergic neurons: Morphine inhibition of spontaneous activity
Korf, J., Bunney, B. S., & Aghajanian, G. K. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90045-4 · Cited by 434 · see citing works
Aghajanian, G. K., & Marek, G. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01224-x · Cited by 376 · see citing works
α1b-Adrenergic Receptors Control Locomotor and Rewarding Effects of Psychostimulants and Opiates
Drouin, C., Darracq, L., Trovero, F., Blanc, G., Glowinski, J., Cotecchia, S., & Tassin, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02873.2002 · Cited by 295 · see citing works
Self-citationDecreased blood pressure response in mice deficient of the α 1b -adrenergic receptor
Cavalli, A., Lattion, A.-L., Hümmler, E., Nenniger-Tosato, M., Pedrazzini, T., Aubert, J.-F., Michel, M. C., Yang, M., Lembo, G., Vecchione, C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11589 · Cited by 289 · see citing works
Self-citationGariano, R. F., & Groves, P. M. (1988) · Brain Research · doi:10.1016/0006-8993(88)90606-3 · Cited by 286 · see citing works
Robinson, T. E., Becker, J. B., & Presty, S. K. (1982) · Brain Research · doi:10.1016/0006-8993(82)90690-4 · Cited by 277 · see citing works
Sorensen, S. M., Kehne, J. H., Fadayel, G. M., Humphreys, T. M., Ketteler, H., Sullivan, C. K., Taylor, V. L., & Schmidt, C. J. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38366-7 · Cited by 258 · see citing works
Darracq, L., Blanc, G., Glowinski, J., & Tassin, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02729.1998 · Cited by 252 · see citing works
Self-citationVezina, P., & Stewart, J. (1989) · Brain Research · doi:10.1016/0006-8993(89)91140-2 · Cited by 240 · see citing works
Marek, G. J., & Aghajanian, G. K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00945-5 · Cited by 221 · see citing works
Ventura, R., Cabib, S., Alcaro, A., Orsini, C., & Puglisi‐Allegra, S. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01879.2003 · Cited by 197 · see citing works
霊長類大脳皮質の5‐ヒドロキシトリプタミン2Aセロトニン受容体 錐体細胞先端樹状突起での幻覚剤及び抗精神病剤の作用部位
Jakab, R. L., & Goldman‐Rakic, P. S. (1998) · Cited by 182 · see citing works
Doherty, M. D., & Pickel, V. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02062-x · Cited by 178 · see citing works
Changes in Extracellular Dopamine Induced by Morphine and Cocaine: Crucial Control by D2 Receptors
Rougé‐Pont, F., Usiello, A., Benoit‐Marand, M., Gonon, F., Piazza, P. V., & Borrelli, E. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03293.2002 · Cited by 177 · see citing works
Jolas, T., & Aghajanian, G. K. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00103-0 · Cited by 171 · see citing works
Millan, M. J., Brocco, M., Gobert, A., Joly, F., Bervoets, K., Rivet, J., Newman‐Tancredi, A., Audinot, V., & Maurel, S. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00858.x · Cited by 139 · see citing works
Tao, R., & Auerbach, S. B. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00154-b · Cited by 134 · see citing works
O‘Neill, M. F., Heron-Maxwell, C., & Shaw, G. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00240-8 · Cited by 134 · see citing works
Antagonism of 5-Hydroxytryptamine2A Receptors Attenuates the Behavioral Effects of Cocaine in Rats
McMahon, L. R., & Cunningham, K. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29546-x · Cited by 133 · see citing works
Blanc, G., Trovero, F., Vezina, P., Hervé, D., Godeheu, A. ‐., Glowinski, J., & Tassin, J. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00272.x · Cited by 132 · see citing works
Self-citationSchreiber, R., Brocco, M., & Millan, M. J. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90643-2 · Cited by 129 · see citing works
Florin, S. M., Kuczenski, R. T., & Segal, D. S. (1994) · Brain Research · doi:10.1016/0006-8993(94)91570-9 · Cited by 124 · see citing works
Dopamine Receptor Antagonists Fail to Prevent Induction of Cocaine Sensitization
White, F. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00093-6 · Cited by 121 · see citing works
Rinaldi, M. L., Congy, C., Santucci, V., Simiand, J., Gautret, B., Neliat, G., Labeeuw, B., Fur, G. L., Soubrié, P., & Brelière, J. C. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10821-5 · Cited by 116 · see citing works
McMahon, L. R., Filip, M., & Cunningham, K. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07781.2001 · Cited by 114 · see citing works
Drouin, C., Blanc, G., Villégier, A., Glowinski, J., & Tassin, J. (2001) · Synapse · doi:10.1002/syn.10023 · Cited by 112 · see citing works
Self-citationReversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist
Moser, P. C., Moran, P. M., Frank, R. A., & Kehne, J. H. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00090-3 · Cited by 111 · see citing works
Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys.
Spealman, R. D. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12081-8 · Cited by 104 · see citing works
Prazosin: Effect on psychomotor-stimulant cues and locomotor activity in mice
Snoddy, A. M., & Tessel, R. E. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90156-6 · Cited by 99 · see citing works
Long lasting changes in morphine‐induced mesolimbic dopamine release after chronic morphine exposure
Spanagel, R., Almeida, O. F. X., & Shippenberg, T. S. (1993) · Synapse · doi:10.1002/syn.890140307 · Cited by 97 · see citing works
Auclair, A. L., Cotecchia, S., Glowinski, J., & Tassin, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09150.2002 · Cited by 89 · see citing works
Self-citationWoolverton, W. L. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90618-6 · Cited by 88 · see citing works
Serotonin Induces EPSCs Preferentially in Layer V Pyramidal Neurons of the Frontal Cortex in the Rat
Lambe, E. K. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.10.974 · Cited by 86 · see citing works
Crawford, C. A., Choi, F., Kohutek, J. L., Yoshida, S. T., & McDougall, S. A. (2003) · Synapse · doi:10.1002/syn.10301 · Cited by 83 · see citing works
Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization
Jeziorski, M. C., & White, F. J. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00779-7 · Cited by 71 · see citing works
Discriminative Stimulus Properties of Cocaine: Enhancement by Monoamine Reuptake Blockers
Kleven, M. S., & Koek, W. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37310-0 · Cited by 67 · see citing works
Receptor subtype and density determine the coupling repertoire of the 5-ht2 receptor subfamily
Lucaites, V. L., Nelson, D. L. G., Wainscott, D. B., & Baez, M. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00423-7 · Cited by 67 · see citing works
Knobelman, D. A., Hen, R., Blendy, J. A., & Lucki, I. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29478-7 · Cited by 63 · see citing works
Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration
Ikemoto, K., Nishimura, A., Okado, N., Mikuni, M., Nishi, K., & Nagatsu, I. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02237-4 · Cited by 56 · see citing works
Auclair, A. L., Blanc, G., Glowinski, J., & Tassin, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02714.x · Cited by 55 · see citing works
Self-citationMulder, A. H., Hogenboom, F., Wardeh, G., & Schoffelmeer, A. N. M. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb05624.x · Cited by 53 · see citing works
Sorensen, S. M., Humphreys, T. M., Taylor, V. L., & Schmidt, C. J. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11377-3 · Cited by 44 · see citing works
Vezina, P., Blanc, G., Glowinski, J., & Tassin, J. (1994) · Synapse · doi:10.1002/syn.890160204 · Cited by 42 · see citing works
Self-citationDarracq, L., Drouin, C., Blanc, G., Glowinski, J., & Tassin, J. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00578-9 · Cited by 41 · see citing works
Self-citationAntagonism of the behavioral effects of cocaine and d-amphetamine by prazosin
Tessel, R. E., & Barrett, J. (1986) · Psychopharmacology · doi:10.1007/bf00174057 · Cited by 36 · see citing works
Cortical α1-adrenergic regulation of acute and sensitized morphine locomotor effects
Drouin, C., Blanc, G., Trovero, F., Glowinski, J., & Tassin, J. (2001) · Neuroreport · doi:10.1097/00001756-200111160-00022 · Cited by 31 · see citing works
Self-citationBerthold, C. W., Gonzales, R. A., & Moerschbaecher, J. M. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90646-w · Cited by 30 · see citing works
Ryan, L. J., Tepper, J. M., Young, S. J., & Groves, P. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)91483-0 · Cited by 22 · see citing works
Cornea-Hébert (1999) · doi:10.1002/(sici)1096-9861(19990628)409:2
Flagged first, then by citations
1 of the 63 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission
Alex, K. D., & Pehek, E. A. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.004 · Cited by 658 · see citing works
Opponency revisited: competition and cooperation between dopamine and serotonin
Boureau, Y.-L., & Dayan, P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.151 · Cited by 456 · see citing works
Goodman, A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.030 · Cited by 412 · see citing works
The role of serotonin 5-HT2A receptors in memory and cognition
Zhang, G., & Stackman, R. W. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00225 · Cited by 386 · see citing works
There and Back Again: A Tale of Norepinephrine and Drug Addiction
Weinshenker, D., & Schroeder, J. P. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301263 · Cited by 347 · see citing works
The role of serotonin in drug use and addiction
Müller, C. P., & Homberg, J. R. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.007 · Cited by 332 · see citing works
Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission
Snyder, G. L., Vanover, K. E., Zhu, H., Miller, D. B., O'Callaghan, J. P., Tomesch, J., Li, P., Zhang, Q., Krishnan, V., Hendrick, J. P., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3704-1 · Cited by 291 · see citing works
López‐Arnau, R., Martínez-Clemente, J., Pubill, D., Escubedo, E., & Camarasa, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01998.x · Cited by 196 · see citing works
Modulating the Neuromodulators: Dopamine, Serotonin, and the Endocannabinoid System
Peters, K. Z., Cheer, J. F., & Tonini, R. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.02.001 · Cited by 171 · see citing works
Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse
Bubar, M. J., & Cunningham, K. A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00916-3 · Cited by 139 · see citing works
Pothakos, K., Kurz, M. J., & Lau, Y.-S. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-6 · Cited by 134 · see citing works
Schank, J. R., Ventura, R., Puglisi‐Allegra, S., Alcaro, A., Cole, C. D., Liles, L. C., Seeman, P. M., & Weinshenker, D. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301000 · Cited by 129 · see citing works
Adriani, W., Leo, D., Greco, D., Rea, M., di Porzio, U., Laviola, G., & Perrone‐Capano, C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300962 · Cited by 130 · see citing works
Role of Noradrenergic Signaling by the Nucleus Tractus Solitarius in Mediating Opiate Reward
Olson, V. G., Heusner, C. L., Bland, R. J., During, M. J., Weinshenker, D., & Palmiter, R. D. (2006) · Science · doi:10.1126/science.1119311 · Cited by 126 · see citing works
Salomon, L., Lanteri, C., Glowinski, J., & Tassin, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600839103 · Cited by 117 · see citing works
Self-citationThe α1-adrenergic receptors: diversity of signaling networks and regulation
Cotecchia, S. (2010) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2010.518152 · Cited by 110 · see citing works
Self-citationMechanisms of Disulfiram-induced Cocaine Abstinence: Antabuse and Cocaine Relapse
Gaval‐Cruz, M., & Weinshenker, D. (2009) · Molecular Interventions · doi:10.1124/mi.9.4.6 · Cited by 110 · see citing works
Navailles, S., Moison, D., Cunningham, K. A., & Spampinato, U. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301414 · Cited by 106 · see citing works
Ninkovic, J., Folchert, A., Makhankov, Y. V., Neuhauss, S. C. F., Sillaber, I., Strähle, U., & Bally‐Cuif, L. (2006) · Journal of Neurobiology · doi:10.1002/neu.20231 · Cited by 99 · see citing works
Lanteri, C., Salomon, L., Torrens, Y., Glowinski, J., & Tassin, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301548 · Cited by 95 · see citing works
Self-citationNK 1 (TACR 1 ) receptor gene ‘knockout’ mouse phenotype predicts genetic association with ADHD
Yan, T., McQuillin, A., Thapar, A., Asherson, P. J., Hunt, S. P., Stanford, S. C., & Gurling, H. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108100255 · Cited by 95 · see citing works
Mitrano, D. A., Schroeder, J. P., Smith, Y., Cortright, J. J., Bubula, N., Vezina, P., & Weinshenker, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.68 · Cited by 94 · see citing works
Tassin, J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.038 · Cited by 91 · see citing works
Self-citationTrigo, J. M., Renoir, T., Lanfumey, L., Hamon, M., Lesch, K., Robledo, P., & Maldonado, R. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.005 · Cited by 91 · see citing works
Endogenous opiates and behavior: 2004
Bodnar, R. J., & Klein, G. E. (2005) · Peptides · doi:10.1016/j.peptides.2005.06.010 · Cited by 86 · see citing works
Ferrucci, M., Limanaqi, F., Ryskalin, L., Biagioni, F., Busceti, C. L., & Fornai, F. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00048 · Cited by 87 · see citing works
Adrenaline Rush: The Role of Adrenergic Receptors in Stimulant-Induced Behaviors
Schmidt, K. T., & Weinshenker, D. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.090118 · Cited by 78 · see citing works
Neuronal pathways linking substance P to drug addiction and stress
Commons, K. G. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.014 · Cited by 74 · see citing works
Masana, M., Bortolozzi, A. A., & Artigas, F. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000908 · Cited by 74 · see citing works
Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review
Divito, A. J., & Leger, R. F. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-06009-x · Cited by 75 · see citing works
Glennon, R. A. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00015-9 · Cited by 71 · see citing works
The serotonin 5-HT 2C receptor and the non-addictive nature of classic hallucinogens
Canal, C. E., & Murnane, K. S. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116677104 · Cited by 67 · see citing works
Zayara, A. E., McIver, G., Valdivia, P. N., Lominac, K. D., McCreary, A. C., & Szumlinski, K. K. (2011) · Psychopharmacology · doi:10.1007/s00213-010-1996-3 · Cited by 64 · see citing works
Pharmacological models of ADHD
Kostrzewa, R. M., Kostrzewa, R. A., Kostrzewa, R. A., Nowak, P. G., & Brus, R. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0826-1 · Cited by 61 · see citing works
Pascoli, V., Valjent, E., Corbillé, A.-G., Corvol, J.-C., Tassin, J.-P., Girault, J.-A., & Hervé, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011809 · Cited by 59 · see citing works
Self-citationPerez, D. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.652152 · Cited by 57 · see citing works
Yan, T. C., Hunt, S. P., & Stanford, S. C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.021 · Cited by 56 · see citing works
Rommelfanger, K. S., Mitrano, D. A., Smith, Y., & Weinshenker, D. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.019 · Cited by 55 · see citing works
Serotonin (5-hydroxytryptamine) 5-HT2A receptor
Anastasio, N. C., Stoffel, E. C., Fox, R. G., Bubar, M. J., Rice, K. C., Moeller, F. G., & Cunningham, K. A. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328345f90d · Cited by 52 · see citing works
Behavioral genetic contributions to the study of addiction-related amphetamine effects
Phillips, T. J., Kamens, H. M., & Wheeler, J. M. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.10.008 · Cited by 50 · see citing works
Mirtazapine prevents induction and expression of cocaine-induced behavioral sensitization in rats
Salazar‐Juárez, A., Barbosa-Méndez, S., Jurado, N., Hernández-Miramontes, R., Leff, P., & Antón, B. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.010 · Cited by 49 · see citing works
The Effects of Locus Coeruleus and Norepinephrine in Methamphetamine Toxicity
Ferrucci, M., Giorgi, F. S., Bartalucci, A., Busceti, C. L., & Fornai, F. (2013) · Current Neuropharmacology · doi:10.2174/157015913804999522 · Cited by 47 · see citing works
Egerton, A., Ahmad, R., Hirani, E., & Grasby, P. M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1226-4 · Cited by 47 · see citing works
Presynaptic Metabotropic Receptors for Acetylcholine and Adrenaline/Noradrenaline
Gilsbach, R., & Hein, L. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-74805-2_9 · Cited by 46 · see citing works
Bayassi-Jakowicka, M., Lietzau, G., Czuba, E., Steliga, A., Waśkow, M., & Kowiański, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189806 · Cited by 43 · see citing works
Ago, Y., Nakamura, S., Baba, A., & Matsuda, T. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fm0070121 · Cited by 44 · see citing works
Alpha‐Noradrenergic Receptors Modulate the Development and Expression of Cocaine Sensitization
Jiménez‐Rivera, C. A., Feliú-Mójer, M. I., & Vázquez‐Torres, R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.039 · Cited by 42 · see citing works
Jîtcă, G., Ősz, B. E., Tero-Vescan, A., & Vari, C.-E. (2021) · Antioxidants · doi:10.3390/antiox10030381 · Cited by 44 · see citing works
Pang, G., Wu, X. G., Tao, X., Mao, R., Liu, X., Zhang, Y.-M., Li, G., Stackman, R. W., Dong, L., & Zhang, G. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00514 · Cited by 41 · see citing works
Desjardins, S., Belkaï, E., Crété, D., Cordonnier, L., Scherrmann, J., Noble, F., & Cynthia Marie-claire, A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.027 · Cited by 39 · see citing works
Novel pharmacotherapeutic targets for the management of drug addiction
Heidbreder, C. A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.038 · Cited by 39 · see citing works
Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs
Sora, I., Li, B., Igari, M., Hall, F. S., & Ikeda, K. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05276.x · Cited by 38 · see citing works
Noradrenergic circuits and signaling in substance use disorders
Downs, A. M., & McElligott, Z. A. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.108997 · Cited by 37 · see citing works
Orejarena, M. J., Lanfumey, L., Maldonado, R. J., & Robledo, P. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001215 · Cited by 38 · see citing works
Zaniewska, M., McCreary, A. C., & Filip, M. (2009) · Synapse · doi:10.1002/syn.20645 · Cited by 35 · see citing works
The Involvement of Norepinephrine in Behaviors Related to Psychostimulant Addiction
Zaniewska, M., Filip, M., & Przegaliński, E. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150121225659 · Cited by 34 · see citing works
Ago, Y., Nakamura, S., Kajita, N., Uda, M., Hashimoto, H., Baba, A., & Matsuda, T. (2007) · Synapse · doi:10.1002/syn.20421 · Cited by 34 · see citing works
Alsene, K. M., Fallace, K., & Bakshi, V. P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.106 · Cited by 34 · see citing works
Chen, Z., Lin, Y., Zhou, Q., Shilin, X., Li, C., Lin, R., Li, J., Chen, Y., Luo, C., & Mo, Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112935 · Cited by 33 · see citing works
Schmidt, K. T., Schroeder, J. P., Foster, S. L., Squires, K. E., Smith, B. M., Pitts, E. G., Epstein, M. P., & Weinshenker, D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.005 · Cited by 33 · see citing works
Purkayastha, S., Ford, J. R., Kanjilal, B., Diallo, S., Inigo, J. D. R., Neuwirth, L. S., Idrissi, A. E., Ahmed, Z., Wieraszko, A., Azmitia, E. C., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07565.x · Cited by 32 · see citing works
Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use
Stevens, M. W., Stevens, M. W., Stevens, M. W., Stevens, M. W., Tawney, R., Tawney, R., Tawney, R., Tawney, R. L., West, C. M., West, C. M., et al. (2013) · mAbs · doi:10.4161/mabs.27620 · Cited by 32 · see citing works
The Effects of Methylphenidate on Knockin Mice with a Methylphenidate-Resistant Dopamine Transporter
Tilley, M. R., & Gu, H. H. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141713 · Cited by 32 · see citing works
The renaissance in psychedelic research: What do preclinical models have to offer
Murnane, K. S. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.08.003 · Cited by 31 · see citing works
Ding, Z., Toalston, J. E., Oster, S. M., McBride, W. J., & Rodd, Z. A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1468-9 · Cited by 31 · see citing works
Zaniewska, M., McCreary, A. C., Wydra, K., & Filip, M. (2010) · Synapse · doi:10.1002/syn.20756 · Cited by 31 · see citing works
Lanteri, C., Hernàndez-Vallejo, S. J., Salomon, L., Doucet, E. L., Godeheu, G., Torrens, Y., Houades, V., & Tassin, J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3315-08.2009 · Cited by 30 · see citing works
Self-citationChemical Composition and Biological Uses of Artemisia absinthium (Wormwood)
Bhat, R. R., Rehman, M. U., Shabir, A., Mir, M. R., Ahmad, A., Khan, R., Masoodi, M. H., Madkhali, H. A., & Ganaie, M. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-04408-4_3 · Cited by 29 · see citing works
Villégier, A., Lotfipour, S., Belluzzi, J. D., & Leslie, F. M. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0799-7 · Cited by 29 · see citing works
Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors
Salomon, L., Lanteri, C., Godeheu, G., Blanc, G., Gingrich, J. A., & Tassin, J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0810-3 · Cited by 28 · see citing works
Self-citationKaneko, Y., Kashiwa, A., Ito, T., Ishii, S., Umino, A., & Nishikawa, T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301111 · Cited by 27 · see citing works
Buck, K., & Ferger, B. (2009) · Synapse · doi:10.1002/syn.20709 · Cited by 26 · see citing works
Involvement of α1-adrenoceptors in conditioned place preference supported by nicotine in rats
Forget, B., Hamon, M., & Thiébot, M.-H. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1559-7 · Cited by 25 · see citing works
Verheij, M. M. M., & Cools, A. R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04259.x · Cited by 25 · see citing works
(±)-Nantenine analogs as antagonists at human 5-HT2A receptors: C1 and flexible congeners
Chaudhary, S., Pecic, S., LeGendre, O., Navarro, H. A., & Harding, W. W. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.048 · Cited by 25 · see citing works
Lupina, M., Tarnowski, M., Baranowska-Bosiacka, I., Talarek, S., Listos, P., Kotlinska, J., Gutowska, I., & Listos, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0993-0 · Cited by 22 · see citing works
Villégier, A., Salomon, L., Blanc, G., Godeheu, G., Glowinski, J., & Tassin, J. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05011.x · Cited by 21 · see citing works
Self-citationStanford, S. C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.03.021 · Cited by 22 · see citing works
Disrupted reinforcement learning during post-error slowing in ADHD
Chevrier, A., Bhaijiwala, M., Lipszyc, J., Cheyne, D., Graham, S., & Schachar, R. (2019) · PLOS ONE · doi:10.1371/journal.pone.0206780 · Cited by 21 · see citing works
Influence of Morphine and Dopamine Receptor Sensitization on Locomotor Activity in Mice
Heidari, P., Sahebgharani, M., Riazi, G. H., & Zarrindast, M. (2006) · Pharmacology · doi:10.1159/000096428 · Cited by 20 · see citing works
Ago, Y., Araki, R., Yano, K., Hiramatsu, N., Kawasaki, T., Chaki, S., Nakazato, A., Onoe, H., Hashimoto, H., Baba, A., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2295-3 · Cited by 19 · see citing works
Neuroprotective effect of wormwood against lead exposure
Kharoubı, O., Slimani, M., & Aoues, A. (2011) · Journal of Emergencies Trauma and Shock · doi:10.4103/0974-2700.76834 · Cited by 19 · see citing works
Gastric pentadecapeptide BPC 157 counteracts morphine-induced analgesia in mice.
Blagaić, A. B., Turčić, P., Blagaić, V., Dubovecak, M., Jelovac, N., Zemba, M., Radić, B., Bečejac, T., Rokotov, D. S., & Sikirić, P. (2009) · PubMed · Cited by 19 · see citing works
Root-Bernstein, R. S., Turke, M. J., Subhramanyam, U. K. T., Churchill, B., & Labahn, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010272 · Cited by 18 · see citing works
Hayes, D. M., Fee, J. R., McCown, T. J., Knapp, D. J., Breese, G. R., Cubero, I., Carvajal, F., Lerma-Cabrera, J. M., Navarro, M., & Thiele, T. E. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00336.x · Cited by 17 · see citing works
Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for α1-adrenoceptor subtypes
Romeo, G., Materia, L., Modica, M. N., Pittalà, V., Salerno, L., Siracusa, M. A., Manetti, F., Botta, M., & Minneman, K. P. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.03.054 · Cited by 17 · see citing works
Biological Treatments for Amfetamine Dependence
Hill, K. P., & Sofuoglu, M. (2007) · CNS Drugs · doi:10.2165/00023210-200721100-00005 · Cited by 16 · see citing works
Treatment of the Psychostimulant-Sensitized Animal Model of Schizophrenia
Shuto, T., & Nishi, A. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00218.x · Cited by 16 · see citing works
Developing Biomarkers for Methamphetamine Addiction
Mendelson, J. E., Baggott, M. J., Flower, K., & Galloway, G. P. (2011) · Current Neuropharmacology · doi:10.2174/157015911795017128 · Cited by 16 · see citing works
O’Leary, A., Kõiv, K., Raudkivi, K., & Harro, J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.003 · Cited by 14 · see citing works
Murnane, K. S., Güner, O. F., Bowen, J. P., Rambacher, K. M., Moniri, N. H., Murphy, T. J., Daphney, C. M., Oppong‐Damoah, A., & Rice, K. C. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.04.003 · Cited by 15 · see citing works
Trovero, F., David, S., Bernard, P., Puech, A. J., Bizot, J., & Tassin, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151242 · Cited by 15 · see citing works
Self-citationProposition d'un modèle neurobiologique de l'addiction
Tassin, J. (2009) · Psychotropes · doi:10.3917/psyt.143.0011 · Cited by 15 · see citing works
Self-citationVelásquez-Martínez, M. C., Santos‐Vera, B., Vélez-Hernández, M. E., Vázquez‐Torres, R., & Jiménez‐Rivera, C. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030790 · Cited by 14 · see citing works
Mpoulimari, I., & Zintzaras, E. (2022) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000316 · Cited by 14 · see citing works
Serotonergic mechanism underlying tranylcypromine enhancement of nicotine self‐administration
Villégier, A., Belluzzi, J. D., & Leslie, F. M. (2010) · Synapse · doi:10.1002/syn.20864 · Cited by 14 · see citing works
Sensitization to the Prosocial Effects of 3,4-Methylenedioxymethamphetamine (MDMA)
Curry, D. W., Berro, L. F., Belkoff, A. R., Sulima, A., Rice, K. C., & Howell, L. L. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.017 · Cited by 13 · see citing works
The Role of Serotonin in Drug Addiction
Müller, C. P., Pum, M. E., Schumann, G., & Huston, J. P. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70099-0 · Cited by 13 · see citing works
Epistasis between neurochemical gene polymorphisms and risk for ADHD
Segurado, R., Bellgrove, M. A., Manconi, F., Gill, M., & Hawi, Z. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.250 · Cited by 13 · see citing works
Neurobiologie de l'addiction : proposition d'un nouveau concept
Tassin, J. (2007) · L information psychiatrique · doi:10.1684/ipe.2007.0092 · Cited by 13 · see citing works
Self-citation
- Authors
- Auclair, A., Drouin, C., Cotecchia, S., Glowinski, J., & Tassin, J.
- Affiliations
- Inserm (FR)
- Corresponding author
- Tassin, Jean‐Pol
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2004-12
- Volume
- 20
- Issue
- 11
- Pages
- 3073-3084
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2007935614
- Semantic Scholar
- 6e7f99f756cb4e158e01c8c27ae8be88a5eaa920
- Cited by
- 163
- References
- 63
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 8 · 2018: 3 · 2017: 5 · 2016: 10 · 2015: 3 · 2014: 11 · 2013: 3 · 2012: 3
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Servier
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- 5-HT2A receptor, alpha1B-adrenergic receptor, dopamine release, ventral striatum, morphine, prazosin, behavioral sensitization, locomotor response, psychostimulants, cocaine, amphetamine, receptor interaction, compensatory mechanisms
- MeSH terms
- Adrenergic alpha-Antagonists, Central Nervous System Stimulants, Anesthetics, Local, Animals, Behavior, Animal, Brain Chemistry, Cocaine, Corpus Striatum, Dextroamphetamine, Dopamine, Drug Administration Schedule, Drug Interactions, Fluorobenzenes, Male, Motor Activity, Narcotics, Phenols, Prazosin, Serotonin Antagonists, Time Factors, Microdialysis, Receptors, Adrenergic, alpha-1, Mice, Knockout, Receptor, Serotonin, 5-HT2A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
